Management of diabetes using adaptive control

International Journal of Adaptive Control and Signal Processing

Volumn 19, Issue 5, 2005, Pages 309-325

  Hovorka, Roman ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Diabetes management; Insulin treatment; Off line adaptation; On line adaptation

Indexed keywords

ADAPTIVE CONTROL SYSTEMS; BIOSENSORS; GLUCOSE; INSULIN; METABOLITES; ONLINE SYSTEMS; PATIENT TREATMENT;

DIABETES MANAGEMENT; INSULIN TREATMENT; OFF-LINE ADAPTATION; ON-LINE ADAPTATION;

DISEASES;

EID: 19944370823     PISSN: 08906327     EISSN: None     Source Type: Journal    
DOI: 10.1002/acs.851     Document Type: Review

References (105)

1. Diabetic Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993; 329:977-986.
2. Turner RC, Holman RR, Cull CA, Stratton IM, Matthews DR, Frighi V, Manley SE, Neil A, McElroy K, Wright D, Kohner E, Fox C, Hadden D, Mehta Z, Smith A, Nugent Z, Peto R, Adlel AI, Mann JI, Bassett PA, Oakes SF, Dornan TL, Aldington S, Lipinski H, Collum R, Harrison K, MacIntyre C, Skinner S, Mortemore A, Nelson D, Cockley S, Levien S, Bodsworth L, Willox R, Biggs T, Dove S, Beattie E, Gradwell M, Staples S, Lam R, Taylor F, Leung L, Carter RD, Brownlee SM, Fisher KE, Islam K, Jelfs R, Williams PA, Williams FA, Sutton PJ, Ayres A, Logie LJ, Lovatt C, Evans MA, Stowell LA, Ross I, Kennedy IA, Croft D, Keen AH, Rose C, Raikou M, Fletcher AE, Bulpitt C, Battersby C, Yudkin JS, Stevens R, Stearn MR, Palmer SL, Hammersley MS, Franklin SL, Spivey RS, Levy JC, Tidy CR, Bell NJ, Steemson J, Barrow BA, Coster R, Waring K, Nolan L, Truscott E, Walravens N, Cook L, Lampard H, Merle C, Parker P, McVittie J, Draisey I, Murchison LE, Brunt AHE, Williams MJ, Pearson DW, Petrie XMP, Lean MEJ, Walmsley D, Lyall F, Christie E, Church J, Thomson E, Farrow A, Stowers JM, Stowers M, McHardy K, Patterson N, Wright AD, Levi NA, Shearer AGI, Thompson RJW, Taylor G, Rayton S, Bradbury M, Glover A, Smyth-Osbourne A, Parkes C, Graham J, England P, Gyde S, Eagle C, Chakrabarti B, Smith J, Sherwell J, Oakley NW, Whitehead MA, Hollier GP, Pilkington T, Simpson J, Anderson M, Martin S, Kean J, Rice B, Rolland A, Nisbet J, Kohner EM, Dornhorst A, Doddridge MC, Dumskyij M, Walji S, Sharp P, Sleightholm M, Vanterpool G, Frost G, Roseblade M, Elliott S, Forrester S, Foster M, Myers K, Chapman R, Hayes JR, Henry RW, Featherston MS, Archbold GPR, Copeland M, Harper R, Richardson I, Davison HA, Alexander L, Scarpello JHB, Shiers DE, Tucker RJ, Worthington JRH, Angris S, Bates A, Walton J, Teasdale M, Browne J, Stanley S, Davis BA, Strange RC, Hadden DR, Kennedy L, Atkinson AB, Bell PM, McCance DR, Rutherford J, Culbert AM, Hegan C, Tennet H, Webb N, Robinson I, Holmes J, Nesbitt S, Spathis AS, Hyer S, Nanson ME, James LM, Tyrell JM, Davis C, Strugnell P, Booth M, Petrie H, Clark D, Hulland S, Barron JL, Gould BC, Singer J, Badenoch A, McGregor M, Isenberg L, Eckert M, Alibhai K, Marriot E, Cox C, Price R, Fernandez M, Ryle A, Clarke S, Wallace G, Mehmed E, Lankester JA, Howard E, Waite A, MacFarlane S, Greenwood RH, Wilson J, Denholm MJ, Temple RC, Whitfield K, Johnson F, Munroe C, Gorick S, Duckworth E, Fatman M, Rainbow S, Borthwick L, Wheatcroft DJ, Seaman RJ, Christie RA, Wheatcroft W, Musk P, White J, McDougal S, Bond M, Raniga P, Day JL, Doshi MJ, Wilson JG, Howard-Williams JR, Humphreys H, Graham A, Hicks K, Hexman S, Bayliss P, Pledger D, Newton RW, Jung RT, Roxburgh C, Kilgallon B, Dick L, Waugh N, Kilby S, Ellingford A, Burns J, Fox CV, Holloway MC, Coghill HM, Hein N. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (U.K.PDS 33). Lancet 1998; 352:837-853.
3. Gilmer TP, OConnor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care 1997; 20:1847-1853.
4. Lehmann ED, Deutsch T. Application of computers in diabetes care - a review. II. Computers for decision support and education. Medical Informatics (London) 1995; 20:303-329.
5. Bellazzi R, Nucci G, Cobelli C. The subcutaneous route to insulin-dependent diabetes therapy. IEEE Engineering in Medicine and Biology Magazine 2001; 20:54-64.
6. Parker RS, Doyle III FJ, Peppas NA. The intravenous route to blood glucose control. IEEE Engineering in Medicine and Biology Magazine 2001; 20:65-73.
7. Bellazzi R. Electronic management systems in diabetes mellitus - impact on patient outcomes. Disease Management & Health Outcomes 2003; 11:159-171.
8. Langer O, Mazze RS. Diabetes in pregnancy: evaluating self-monitoring performance and glycaemic control with memory-based reflectance meters. American Journal of Obstetrics and Gynecology 1986; 155:635-637.
9. Hovorka R, Svacina S, Carson ER, Williams CD, Sonksen PH. A consultation system for insulin therapy. Computer Methods and Programs in Biomedicine 1990; 32:303-310.
10. Shimauchi T, Kugai N, Nagata N, Takatani O. Microcomputer-aided insulin dose determination in intensified conventional insulin therapy. IEEE Transactions on Biomedical Engineering 1988; 35:167-171.
11. Berger MP, Rodbard D. A pharmacodynamic approach to optimizing insulin therapy. Computer Methods and Programs in Biomedicine 1991; 34:241-253.
12. Berger MP, Rodbard D. Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection. Diabetes Care 1989; 12:725-736.
13. Sachedina N, Pickup JC. Performance assessment of the Medtronic-MiniMed continuous glucose monitoring system and its use for measurement of glycaemic control in Type 1 diabetic subjects. Diabetic Medicine 2003; 20:1012-1015.
14. Boroujerdi MA, Carson ER, Harvey FE, Williams CD, Sonksen PH. Diabeta - a knowledge-based system for the management of diabetes. Proceedings of Ninth Annual Conference of the Engineering in Medicine and Biology Society. IEEE: New York, 1987; 667-668.
15. Salzsieder E, Fischer U, Stoewhas H, Thierbach U, Rutscher A, Menzel R, Albrecht G. A model-based system for the individual prediction of metabolic response to improve therapy in type 1 diabetes. Hormone and Metabolic Research 1990; 24:10-19.
16. Salzsieder E, Albrecht G, Fischer U, Freyse EJ. Kinetic modeling of the glucoregulatory system to improve insulin therapy. IEEE Transactions on Biomedical Engineering 1985; 32:846-855.
17. Rutscher A, Salzsieder E, Fischer U. KADIS - model-aided education in type 1 diabetes. Computer Methods and Programs in Biomedicine 1994; 41:205-215.
18. Bleckert G, Oppel UG, Salzsieder E. Mixed graphical models for simultaneous model identification and control applied to the glucose-insulin metabolism. Computer Methods and Programs in Biomedicine 1998; 56: 141-155.
19. Hovorka R, Andreassen S, Benn JJ, Olessen KG, Carson ER. Causal probabilistic network modelling - an illustration of its role in the management of chronic diseases. IBM Systems Journal 1992; 31:635-648.
20. Hejlesen OK, Andreassen S, Frandsen NE, Petersen T, Sando SH, Hovorka R, Cavan DA. Using a double blind controlled clinical trial to evaluate the function of a diabetes advisory system: a feasible approach. Computer Methods and Programs in Biomedicine 1998; 56:165-174.
21. Cavan DA, Hovorka R, Hejlesen OK, Andreassen S, Sonksen PH. Use of the DIAS model to predict unrecognised hypoglycaemia in patients with insulin dependent diabetes. Computer Methods and Programs in Biomedicine 1996; 50:241-246.
22. Cavan DA, Hejlesen OK, Hovorka R, Ewans JA, Metcalfe JA, Cavan ML, Halim M, Andreassen S, Carson ER, Sonksen PH. Preliminary experience of the DIAS computer model in providing insulin dose advice to patients with insulin dependent diabetes. Computer Methods and Programs in Biomedicine 1998; 56:157-164.
23. Rix H, Hejlesen OK, Andreassen S, Lange A, Schaarup J, Ostergaard E, Andersen UM. Insulin dose adjustments in adolescents by DIAS. Proceedings Computers in Diabetes '96, Graz, 1996; 51.
24. Tudor RS, Hovorka R, Cavan DA, Meeking D, Hejlesen OK, Andreassen S. DIAS-NIDDM - a model-based decision support system for insulin dose adjustment in insulin-treated subjects with NIDDM. Computer Methods and Programs in Biomedicine 1998; 56:175-191.
25. Cavan DA, Everett J, Plougmann S, Hejlesen OK. Use of the Internet to optimize self-management of type 1 diabetes: preliminary experience with DiasNet. Journal of Telemedicine and Telecare 2003; 9:S50-S52.
26. Deutsch T, Roudsari AV, Leicester HJ, Theodorou T, Carson ER, Sonksen PH. UTOPIA: a consultation system for visit-by-visit diabetes management. Medical Informatics 1996; 21:345-358.
27. Bellazzi R, Magni P, De Nicolao G. Bayesian analysis of blood glucose time series from diabetes home monitoring. IEEE Transactions on Biomedical Engineering 2000; 47:971-975.
28. Zimmet P, Lang A, Mazze RS, Endersbee R. Computer-based patient monitoring systems. Use in research and clinical practice. Diabetes Care 1988; 11(Suppl.):62-66.
29. Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK. Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care 2003; 26:1475-1479.
30. Klonoff DC. Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? Diabetes Care 2003; 26:1626-1628.
31. Biermann E, Dietrich W, Rihl J, Standl E. Are there time and cost savings by using telemanagement for patients on intensified insulin therapy? A randomised, controlled trial. Computer Methods and Programs in Biomedicine 2002; 69:137-146.
32. Bellazzi R, Riva A, Larizza C, Fiocchi S, Stefanelli M. A distributed system for diabetic patient management. Computer Methods and Programs in Biomedicine 1998; 56:93-107.
33. Bellazzi R, Larizza C, Montani S, Riva A, Stefanelli M, d'Annunzio G, Lorini R, Gomez EJ, Hernando E, Brugues E, Cermeno J, Corcoy R, de Leiva A, Cobelli C, Nucci G, Del Prato S, Maran A, Kilkki E, Tuominen J. A telemedicine support for diabetes management: the T-IDDM project. Computer Methods and Programs in Biomedicine 2002; 69:147-161.
34. Bellazzi R, Siviero C, Stefanelli M, De Nicolao G. Adaptive controllers for intelligent monitoring. Artificial Intelligence in Medicine 1995; 7:515-540.
35. Bellazzi R, Arcelloni M, Bensa G, Blankenfeld H, Brugues E, Carson E, Cobelli C, Cramp D, d'Annunzio G, De Cata P, de Leiva A, Deutsch T, Fratino P, Gazzaruso C, Garcia A, Gergely T, Gomez E, Harvey F, Ferrari P, Hernando E, Boulos MK, Larizza C, Ludekke H, Maran A, Nucci G, Pennati C, Ramat S, Roudsari A, Rigla M, Stefanelli M. Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients. Diabetes Technology & Therapeutics 2003; 5:621-629.
36. Hernando ME, Gomez EJ, del Pozo F, Corcoy R. DIABNET: a qualitative model-based advisory system for therapy planning in gestational diabetes. Medical Informatics (London) 1996; 21:359-374.
37. Gomez EJ, Hernando ME, Garcia A, del Pozo F, Cermeno J, Corcoy R, Brugues E, de Leiva A. Telemedicine as a tool for intensive management of diabetes: the DIABTel experience. Computer Methods and Programs in Biomedicine 2002; 69:163-177.
38. Wojcicki JM, Ladyzynski P, Krzymien J, Jozwicka E, Blachowicz J, Janczewska E, Czajkowski K, Karnafel W. What we can really expect from telemedicine in intensive diabetes treatment: results from 3-year study on type 1 pregnant diabetic women. Diabetes Technology & Therapeutics 2001; 3:581-589.
39. Meneghini LF, Albisser AM, Goldberg RB, Mintz DH. An electronic case manager for diabetes control. Diabetes Care 1998; 21:591-596.
40. Andersen RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment - results of a randomized controlled trial. Diabetes Care 1995; 18:943-949.
41. Muhlhauser I, Jorgens V, Berger M, Graninger W, Gurtler W, Hornke L, Kunz A, Schernthaner G, Scholz V, Voss HE. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983; 25:470-476.
42. Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 1995; 18:625-630.
43. Lemozy-Cadroy S, Crognier S, Gourdy P, Chauchard MC, Chale JP, Tauber JP, Hanaire-Broutin H. Intensified treatment of type 1 diabetes: prospective evaluation at one year of a therapeutic patient education programme. Diabetes & Metabolism 2002; 28:287-294.
44. Pieber TR, Holler A, Siebenhofer A, Brunner GA, Semlitsch B, Schattenberg S, Zapotoczky H, Rainer W, Krejs GJ. Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria. Diabetic Medicine 1995; 12:349-354.
45. Amiel S, Beveridge S, Bradley C, Gianfrancesco C, Heller S, James P, McKeown N, Newton D, Newton L, Oliver L, Reid H, Roberts S, Robson S, Rollingson J, Scott V, Speight J, Taylor C, Thompson G, Turner E, Wright F. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal 2002; 325:746-749.
46. Lehmann ED, Deutsch T, Carson ER, Sonksen PH. AIDA: an interactive diabetes advisor. Computer Methods and Programs in Biomedicine 1994; 41:183-203.
47. Lehmann ED. Who is downloading the free AIDA v4.3a interactive educational diabetes computer software? A 1-year survey of 3864 downloads. Diabetes Technology & Therapeutics 2003; 5:879-890.
48. Levy M, Ferrand P, Chirat V. SESAM-DIABETE, an expert system for insulin-requiring diabetic patient education. Computers and Biomedical Research 1989; 22:442-453.
49. Pernick NL, Rodbard D. Personal computer programs to assist with self-monitoring of blood glucose and self-adjustment of insulin dosage. Diabetes Care 1986; 9:61-69.
50. Hauser T, Kraegen EW, Campbell LV, Compton PJ, Sammut C, Chisholm DJ. Assessment of experts approach to insulin therapy and development of a simulator for diabetes insulin adjustment. Diabetes Care 1992; 15: 221-231.
51. Chanoch LH, Jovanovic L, Peterson CM. The evaluation of a pocket computer as an aid to insulin dose determination by patients. Diabetes Care 1985; 8:172-176.
52. Schiffrin A, Mihic M, Leibel BS, Albisser AM. Computer-assisted insulin dosage adjustment. Diabetes Care 1985; 8:545-552.
53. Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). Journal of Pediatrics Endocrinology & Metabolism 1999; 12:751-758.
54. Tamada JA, Garg S, Jovanovic L, Pitzer KR, Fermi S, Potts RO. Noninvasive glucose monitoring - comprehensive clinical results. The Journal of the American Medical Association 1999; 282:1839-1844.
55. Tamada JA, Bohannon NJV, Potts RO. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nature Medicine 1995; 1:1198-1201.
56. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M. Continuous subcutaneous glucose monitoring in diabetic patients - a multicenter analysis. Diabetes Care 2002; 25:347-352.
57. Koschinsky T, Heinemann L. Sensors for glucose monitoring: technical and clinical aspects. Diabetes-Metabolism Research and Reviews 2001; 17:113-123.
58. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Research and Clinical Practice 1999; 46: 183-190.
59. Schaepelynck-Belicar P, Vague P, Simonin G, Lassmann-Vague V. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). Diabetes & Metabolism 2003; 29: 608-612.
60. Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 2003; 26:582-589.
61. Howorka K, Pumprla J, Gabriel M, Thoma H, Schabmann A. Computerized generation of circadian sensor modal days with continuous glucose monitoring for comparison of various insulin regimens based on insulin glargine in type 1 diabetes. International Journal of Artificial Organs 2003; 26:728-734.
62. Pfeiffer EF, Thum C, Clemens AH. The artificial beta cell-a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Hormone and Metabolic Research 1974; 6:339-342.
63. Clemens AH, Chang PH, Myers RW. The development of Biostator, a glucose controlled insulin infusion system (GCIIS). Hormone and Metabolic Research 1977; 7(Suppl.):23-33.
64. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes 1974; 23:389-404.
65. Botz CK. An improved control algorithm for an artificial beta-cell. IEEE Transactions on Biomedical Engineering 1974; 23:252-255.
66. Marliss EB, Murray FT, Stokes EF, Zinman B, Nakhooda AF, Denoga A, Leibel BS, Albisser AM. Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes 1977; 26:663-672.
67. Kraegen EW, Campbell LV, Chia YO, Meler H, Lazarus L. Control of blood glucose in diabetics using an artificial pancreas. Australian and New Zealand Journal of Medicine 1977; 7:280-286.
68. Broekhuyse HM, Nelson JD, Zinman B, Albisser AM. Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cell. IEEE Transactions on Biomedical Engineering 1981; 28:678-687.
69. Fischer U, Jutzi E, Albrecht G, Abel P, Salzsieder E, Freyse EJ, Detscheff W, Lemke K. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes. Transactions - American Society for Artificial Internal Organs 1983; 29:488-491.
70. Fischer U, Schenk W, Salzsieder E, Albrecht G, Abel P, Freyse EJ. Does physiological blood glucose control require an adaptive control strategy? IEEE Transactions on Biomedical Engineering 1987; 34:575-582.
71. Swan GW. An optimal control model of diabetes mellitus. Bulletin of Mathematical Biology 1982; 44:793-808.
72. Ollerton RL. Application of optimal control theory to diabetes mellitus. International Journal of Control 1989; 50:2503-2522.
73. Fisher ME, Teo KL. Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics. IEEE Transactions on Biomedical Engineering 1989; 36:479-486.
74. Kienitz KH, Yoneyama T. A robust controller for insulin pumps based on H-infinity theory. IEEE Transactions on Biomedical Engineering 1993; 40:1133-1137.
75. Parker RS, Doyle FJ, Ward JH, Peppas NA. Robust H-infinity glucose control in diabetes using a physiological model. American Institute of Chemical Engineers Journal 2000; 46:2537-2549.
76. Fischer U, Salzsieder E, Freyse EJ, Albrecht G. Experimental validation of a glucose insulin control model to simulate patterns in glucose-turnover. Computer Methods and Programs in Biomedicine 1990; 32:249-258.
77. Shichiri M, Kawamori R, Goriya Y, Yamasaki Y, Nomura M, Hakui N, Abe H. Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas. Diabetologia 1983; 24:179-184.
78. Shichiri M, Kawamori R, Hakui N, Yamasaki Y, Abe H. Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response. Diabetes 1984; 33: 1200-1202.
79. Cobelli C, Mari A. Control of diabetes with artificial systems for insulin delivery-algorithm independent limitations revealed by a modeling study. IEEE Transactions on Biomedical Engineering 1985; 32:840-845.
80. Rave K, Heinemann L, Puhl L, Gudat U, Woodworth JR, Weyer C, Heise T. Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients. Diabetes Care 1999; 22:865-866.
81. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes 1994; 43:396-402.
82. Shimoda S, Nishida K, Sakakida M, Konno Y, Ichinose K, Uehara M, Nowak T, Shichiri M. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Frontiers of Medical and Biological Engineering 1997; 8:197-211.
83. Shichiri M, Sakakida M, Nishida K, Shimoda S. Enhanced, simplified glucose sensors: long-term clinical application of wearable artificial endocrine pancreas. Artificial Organs 1998; 22:32-42.
84. Shimoda S, Nishida K, Sakakida M, Matsuo Y, Araki E. Development of closed-loop intraperitoneal insulin infusion algorithm for a implantable artificial endocrine pancreas. Diabetes 2001; 50(Suppl. 2):A3.
85. Renard E, Costalat G, Moran B, Shah R, Zhang YN, Villegas D, Kolopp M, Lebel R, Bringer J. First combined implantations of a long-term IV glucose sensor and an intra-peritoneal insulin pump in diabetic patients. Diabetes 2001; 50:A3.
86. Renard E, Costalat G, Bringer J. From external to implantable insulin pump, can we close the loop? Diabetes & Metabolism 2002; 28:S19-S25.
87. Parker RS, Doyle III FJ, Peppas NA. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Transactions on Biomedical Engineering 1999; 46:148-157.
88. Lynch SM, Bequette BW. Estimation-based model predictive control of blood glucose in type I diabetics: a simulation study. Proceedings of the IEEE 27th Annual Northeast Bioengineering Conference, 2001; 79-80.
89. Lynch SM, Bequette BW. Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements. Proceedings of the 2002 American Control Conference, 2002; 4039-4043.
90. Trajanoski Z, Wach P. Neural predictive controller for insulin delivery using the subcutaneous route. IEEE Transactions on Biomedical Engineering 1998; 45:1122-1134.
91. Trajanoski Z, Regittnig W, Wach P. Simulation studies on neural predictive control of glucose using subcutaneous route. Computer Methods and Programs in Biomedicine 1998; 56:133-140.
92. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. American Journal of Physiology 1979; 236:E667-E677.
93. Cobelli C, Bettini F, Caumo A, Quon MJ. Overestimation of minimal model glucose effectiveness in presence of insulin response is due to undermodeling. American Journal of Physiology 1998; 275:E1031-E1036.
94. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the surgical intensive care unit. The New England Journal of Medicine 2001; 345:1359-1367.
95. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27:461-467.
96. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Transactions on Information Technology in Biomedicine 2003; 7:43-53.
97. Brunetti P, Cobelli C, Cruciani P, Fabietti PG, Filippucci F, Santeusanio F, Sarti E. A simulation study on a self-tuning portable controller of blood-glucose. International Journal of Artificial Organs 1993; 16:51-57.
98. Domingo JFC, Ruiz R, Aldana F, SerranoRios M. Adaptation drift suppression in blood glucose self-tuning control. Artificial Organs 1997; 21:272-277.
99. Candas B, Radziuk J. An adaptive plasma glucose controller based on a nonlinear insulin/glucose model. IEEE Transactions on Biomedical Engineering 1994; 41:116-124.
100. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini-Federici M, Pieber TR, Schaller H, Schaupp L, Vering T, Wilinska M. Non-linear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiological Measurement 2004; 25:905-920.
101. Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC, Tudor RS, Umpleby AM, Jones RH. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. American Journal of Physiology 2002; 282:E992-E1007.
102. Livesey G, Wilson PD, Dainty JR, Brown JC, Faulks RM, Roe MA, Newman TA, Eagles J, Mellon FA, Greenwood RH. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. American Journal of Physiology 1998; 275:E717-E728.
103. Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Orsini-Federici M, Massi-Benedetti M, Hutzli I, Zaugg C, Kaufman H, Both M, Vering T, Schaller HC, Schaupp L, Bodelenz M, Pieber TR. Closing the loop: the Adicol experience. Diabetes Technology & Therapeutics 2004; 6:307-318.
104. Schaller HC, Bodenlenz M, Schaupp L, Plank J, Wach P, Pieber TR, Chassin LJ, Wilinska M, Hovorka R, Haueter U, Vering T, Orsini-Federici M, Celleno R, Akwe J, Canonico V, Massi-Benedetti M. MPC algorithm controls blood glucose in patients with type 1 diabetes mellitus under fasting conditions using the IV-SC route. Diabetes Technology & Therapeutics 2002; 4:234.
105. Schaller HC, Schaupp LA, Bodenlenz M, Sommer R, Wutte A, Semlitsch B, Chassin LJ, Wilinska M, Hovorka R, Wach P, Pieber TR. Feasibility of the SC-SC route for an extracorporeal artificial pancreas. Diabetes 2002; 51(Suppl. 2):462.